Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lineage Cell Therapeutics (LCTX) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Lineage Cell Therapeutics (LCTX) over the last 16 years, with Q3 2025 value amounting to $29000.0.

  • Lineage Cell Therapeutics' Income from Non-Controlling Interests fell 1212.12% to $29000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $148000.0, marking a year-over-year increase of 12769.23%. This contributed to the annual value of $27000.0 for FY2024, which is 28571.43% up from last year.
  • According to the latest figures from Q3 2025, Lineage Cell Therapeutics' Income from Non-Controlling Interests is $29000.0, which was down 1212.12% from $100000.0 recorded in Q2 2025.
  • Lineage Cell Therapeutics' Income from Non-Controlling Interests' 5-year high stood at $100000.0 during Q2 2025, with a 5-year trough of -$200000.0 in Q4 2021.
  • Its 5-year average for Income from Non-Controlling Interests is -$9052.6, with a median of -$8000.0 in 2021.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first tumbled by 163846.15% in 2021, then surged by 86923.08% in 2025.
  • Lineage Cell Therapeutics' Income from Non-Controlling Interests (Quarter) stood at -$200000.0 in 2021, then soared by 96.0% to -$8000.0 in 2022, then skyrocketed by 862.5% to $61000.0 in 2023, then plummeted by 62.3% to $23000.0 in 2024, then increased by 26.09% to $29000.0 in 2025.
  • Its Income from Non-Controlling Interests was $29000.0 in Q3 2025, compared to $100000.0 in Q2 2025 and -$4000.0 in Q1 2025.